Literature DB >> 10229819

Intraepithelial lymphocytes traffic to the intestine and enhance resistance to Toxoplasma gondii oral infection.

D Buzoni-Gatel1, H Debbabi, M Moretto, I H Dimier-Poisson, A C Lepage, D T Bout, L H Kasper.   

Abstract

Toxoplasma gondii Ag-primed intraepithelial lymphocytes (IEL) from the mouse intestine have been shown to be protective against an lethal parasite challenge when adoptively transferred into recipient mice. In the present study, we observed that Ag-primed IEL traffic to the intestine of naive mice following i.v. administration. Primed and CD8beta+ IEL were the most efficient cells at homing to the host organ. In congenic mice, IEL migrated from intestine within several hours posttransfer. On Ag reexposure, the primed IEL return to the intestine where they enhance resistance as determined by reduction in the number of brain cysts. Treatment of recipient mice with anti-alpha4 and anti-alphaE Abs partially inhibited IEL intestinal homing. The Ab treatment dramatically impaired resistance to a subsequent oral infection. These finding indicate that lymphocyte homing is an important parameter in establishing long term immunity to recurrent infection with this parasite.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229819

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments.

Authors:  F Velge-Roussel; P Marcelo; A C Lepage; D Buzoni-Gatel; D T Bout
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 2.  Ups and downs of mucosal cellular immunity against protozoan parasites.

Authors:  L H Kasper; D Buzoni-Gatel
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 3.  Long-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic Infections.

Authors:  Kelly J Pittman; Laura J Knoll
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

Review 4.  Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger.

Authors:  Charlotte E Egan; Sara B Cohen; Eric Y Denkers
Journal:  Immunol Cell Biol       Date:  2011-11-08       Impact factor: 5.126

5.  An early intestinal mucosal source of gamma interferon is associated with resistance to and control of Cryptosporidium parvum infection in mice.

Authors:  Brett A Leav; Masaru Yoshida; Kathleen Rogers; Seth Cohen; Nihal Godiwala; Richard S Blumberg; Honorine Ward
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  Replication and distribution of Toxoplasma gondii in the small intestine after oral infection with tissue cysts.

Authors:  Beth Gregg; Betsy C Taylor; Beena John; Elia D Tait-Wojno; Natasha M Girgis; Natalie Miller; Sagie Wagage; David S Roos; Christopher A Hunter
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

7.  Intraepithelial lymphocytes, goblet cells and VIP-IR submucosal neurons of jejunum rats infected with Toxoplasma gondii.

Authors:  Débora M G Sant'Ana; Marcelo B Góis; Jacqueline N Zanoni; Aristeu V da Silva; Cleverton J T da Silva; Eduardo J A Araújo
Journal:  Int J Exp Pathol       Date:  2012-08       Impact factor: 1.925

Review 8.  Border maneuvers: deployment of mucosal immune defenses against Toxoplasma gondii.

Authors:  S B Cohen; E Y Denkers
Journal:  Mucosal Immunol       Date:  2014-04-09       Impact factor: 7.313

9.  The effect of oral tolerance on the roles of small intestinal intraepithelial lymphocytes in murine colitis induced by dextran sodium sulfate.

Authors:  Yuefang Ye; Min Yue; Xi Jin; Shaohua Chen; Youming Li
Journal:  Int J Colorectal Dis       Date:  2012-01-14       Impact factor: 2.571

10.  Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii.

Authors:  Ildiko R Dunay; Renato A Damatta; Blima Fux; Rachel Presti; Suellen Greco; Marco Colonna; L David Sibley
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.